載入...
Use of Micronized Purified Flavonoid Fraction Together with Rivaroxaban Improves Clinical and Ultrasound Outcomes in Femoropopliteal Venous Thrombosis: Results of a Pilot Clinical Trial
INTRODUCTION: The aim of this study was to assess the impact of adding long-term micronized purified flavonoid fraction (MPFF) to standard treatment of femoropopliteal deep vein thrombosis (DVT). METHODS: This pilot, comparative, open-label study with blinded outcome assessor enrolled patients with...
Na minha lista:
| 發表在: | Adv Ther |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Springer Healthcare
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6318234/ https://ncbi.nlm.nih.gov/pubmed/30539384 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-018-0849-z |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|